Healix is a premier provider of outpatient infusion therapy management services.

Healix manages alternate-site infusion therapy on behalf of physicians, hospitals and medical institutions, supporting outpatient treatment for patients with chronic and acute medical conditions. The Company provides a range of services for optimal patient comfort and care, and also offers central pharmacy services, with patient-specific compounding from a 503A licensed pharmacy facility.

Healix was acquired by Singlepoint Healthcare in 2026.